Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 11 days ago
Share
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
450 patients around the world
Available in
Argentina
GlaxoSmithKline
450
Patients around the world
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Study
B-Sure
Sponsor
GlaxoSmithKline
Study type
Interventional
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT04954859
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent